NYU Langone Health

550 1st. Avenue, New York, New York 10016

New York University Langone Health, often shortened to NYU Langone, features a mesothelioma expert along with many other patient-first oncologists and surgeons. The hospital is located in New York City and offers the Perlmutter Cancer Center.

doctor image

focus icon

Pleural Mesothelioma and

Peritoneal Mesothelioma

location icon

NYU Langone Health

550 1st. Avenue

New York, New York

specialist icon

Dr. Harvey Pass

Dr. Amie Kent

doctor image

JUMP TO A TOPIC

jump to icon

SCROLL TO TOP


More About Mesothelioma Treatment at NYU Langone Health

The NYU Langone website lists 34 medical professionals as capable of treating mesothelioma. These doctors’ titles include:

  • Thoracic surgeon
  • Medical oncologist
  • Radiation oncologist
  • Pulmonary medicine specialist

Dr. Harvey Pass is First Director of Thoracic Surgery at the hospital. He directs mesothelioma care and performs surgeries for malignant pleural mesothelioma, which is a thoracic cancer. It forms in the thin lining of the lungs. Dr. Pass is co-author of the “100 Questions & Answers About Mesothelioma” book, a valuable resource for patients, families and even medical professionals.

Cancer Center Specialists Icon

Experienced Mesothelioma Specialists

    • Dr. Harvey Pass, First Director of Thoracic Surgery
    • Dr. Amie Kent, thoracic surgeon
    • Dr. Robert Certfolio, thoracic surgeon
    • Dr. Daniel Sterman, pulmonary medicine specialist
Cancer Center Affiliations Icon

Affiliations

    • New York University Grossman School of Medicine
    • Perlmutter Cancer Center
Cancer Center Treatments Icon

Treatment Specialties

    • Pleurectomy/decortication surgery
    • Extrapleural pneumonectomy surgery
    • HIPEC cytoreductive surgery
    • Chemotherapy
    • Radiation therapy
    • Fluid drainage palliative surgery

Get Connected to NYU Langone Health

Get Connected to NYU Langone Health - Form Image

NYU Langone has nearly three dozen medical professionals with experience in the mesothelioma care process. Cancer centers with a large team of mesothelioma doctors usually provide the greatest benefit to patients, whether it’s for hopes of eradicating all tumors or improving comfort through palliative care.

Why Choose NYU Langone?

  • Affiliated with a top medical school and multidisciplinary cancer center
  • Multiple surgeons on staff with mesothelioma experience
  • Protocol in place for mesothelioma to help patients know what to expect








Diagnosis:


Surgery Protocol at NYU Langone Health

One of the surgeries offered at NYU Langone is pleurectomy/decortication for pleural mesothelioma. This surgery is specifically for pleural mesothelioma, which forms in the lining of the lungs. Pleurectomy/decortication removes the lining, along with part or all of the diaphragm and lining of the heart.

NYU Langone says only 20-30% of pleural mesothelioma cases qualify for pleurectomy/decortication. The other option for surgery is extrapleural pneumonectomy, which goes a step further and takes out the affected lung. NYU Langone’s website says chemotherapy often is given before extrapleural pneumonectomy.

The last aggressive surgery is cytoreduction with HIPEC. This is for peritoneal mesothelioma, which is a cancer of the lining in the abdominal cavity. This surgery can take up to 12 hours and involves heated chemotherapy delivered into the abdomen after all visible tumors are removed.

Each surgery requires rehabilitation in the hospital. NYU Langone offers patients the Rusk Rehabilitation center and program for full support during rehab, including a qualified staff to help with breathing and movement exercises.

If chemotherapy is recommended through an IV, it is given in what’s called cycles. These are 21-day increments between chemotherapy treatment. NYU Langone medical oncologists usually recommend 2-4 cycles for mesothelioma.

Cancer Center Ranking Icon

Hospital Ranking

    • Ranked 3rd in the U.S. News & World Report 2022-2023 Hospitals Honor Roll
    • Ranked 1st in New York
    • Ranked 19th for general cancer treatment
    • Ranked 5th in gastrointestinal cancer surgery (peritoneal mesothelioma)
    • Ranked 4th in lung cancer surgery (pleural mesothelioma)

Involvement in Mesothelioma Research

NYU Langone’s research efforts focus around mesothelioma biopsy practices. Diagnosing mesothelioma requires multiple tests, which usually happen after monitoring early symptoms.

The hospital’s Thoracic Oncology Research Program is a National Cancer Institute-designated Biomarker Discovery Laboratory. Biomarkers are the central focus of diagnosing and staging cancers like mesothelioma.

Doctors at NYU Langone are examining proteins in the blood to identify mesothelioma earlier among those exposed to asbestos. Most people aren’t diagnosed for at least 20 years after exposure. If this time can be shortened, it improves the chances of early treatment and prolonged survival.

How to Begin Treatment at NYU Langone

New York University Langone Health has a premier cancer center and staff to welcome mesothelioma patients and families. Before contacting the hospital’s main line, reach out to a patient advocate. They’ll help you with scheduling a consultation and offer guidance for treatment options.

Our lead patient advocate, Karen Ritter, is available to help you or a loved one. Email her at karen@mesotheliomaguide.com for direct communication, or ask for our cancer center recommendations by filling out a form.

Sources & Author

    1. Surgery for Malignant Mesothelioma. NYU Langone Health. Retrieved from: https://nyulangone.org/conditions/malignant-mesothelioma/treatments/surgery-for-malignant-mesothelioma. Accessed: 02/04/2022.
    2. NYU Langone Hospitals. U.S. News & World Report. Retrieved from: https://health.usnews.com/best-hospitals/area/ny/nyu-langone-medical-center-6212925. Accessed: 02/04/2022.
    3. Doctors Who Treat Malignant Mesothelioma. NYU Langone Health. Retrieved from: https://nyulangone.org/conditions/malignant-mesothelioma/doctors. Accessed: 02/08/2022.
    4. Support for Malignant Mesothelioma. NYU Langone Health. Retrieved from: https://nyulangone.org/conditions/malignant-mesothelioma/support. Accessed: 02/08/2022.
    5. Diagnosing Malignant Mesothelioma. NYU Langone Health. Retrieved from: https://nyulangone.org/conditions/malignant-mesothelioma/diagnosis. Accessed: 02/08/2022.
    6. Chemotherapy for Malignant Mesothelioma. NYU Langone Health. Retrieved from: https://nyulangone.org/conditions/malignant-mesothelioma/treatments/chemotherapy-for-malignant-mesothelioma. Accessed: 02/08/2022.
Karen image

About the Writer, Karen Ritter, RN BSN

Karen Ritter, a registered nurse, is the lead patient advocate for Mesothelioma Guide. She has a deep passion for patient care, which includes helping patients and their families search for treatment options at the top mesothelioma cancer centers. She finds the balance between encouraging patients to receive the best treatment possible while enjoying their time with loved ones and friends. Karen is a valuable asset for patients due to her knowledge of mesothelioma, compassion for the victims of this disease and dedication to guiding patients through their treatment journey.